|
EIF2B1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78289999985815E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.005140E-04 |
| Normal-vs-Stage2 |
4.090000E-02 |
| Normal-vs-Stage3 |
5.103300E-03 |
| Normal-vs-Stage4 |
1.332430E-02 |
| Stage1-vs-Stage2 |
9.566800E-01 |
| Stage1-vs-Stage3 |
1.751600E-01 |
| Stage1-vs-Stage4 |
3.001200E-01 |
| Stage2-vs-Stage3 |
3.563200E-01 |
| Stage2-vs-Stage4 |
3.145200E-01 |
| Stage3-vs-Stage4 |
9.449200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.47589999999198E-06 |
| Normal-vs-AfricanAmerican |
6.03729999999469E-05 |
| Normal-vs-Asian |
3.449200E-01 |
| Caucasian-vs-AfricanAmerican |
3.893400E-01 |
| Caucasian-vs-Asian |
9.116200E-01 |
| AfricanAmerican-vs-Asian |
6.995800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.27700000041831E-07 |
| Normal-vs-Female |
1.90176999999014E-05 |
| Male-vs-Female |
6.830000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.351650E-02 |
| Normal-vs-Extreme_Weight |
8.380000E-04 |
| Normal-vs-Obese |
1.564030E-04 |
| Normal-vs-Extreme_Obese |
7.442400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.014400E-01 |
| Normal_Weight-vs-Obese |
4.683400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.480000E-01 |
| Extreme_Weight-vs-Obese |
4.667000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.702400E-01 |
| Obese-vs-Extreme_Obese |
1.497030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6294799999983E-05 |
| Normal-vs-Age(41-60Yrs) |
2.25379999996278E-07 |
| Normal-vs-Age(61-80Yrs) |
4.564300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.330200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.437620E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.997500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.676000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.492810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.467200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.857600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.25120000418855E-09 |
| Normal-VS-Type2 PRCC |
1.116800E-01 |
| Normal-VS-KIRP CIMP |
2.891800E-02 |
| Normal-VS-Unclassified PRCC |
2.619400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.063550E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.526400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.110200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.005800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.346300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.947200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.336200E-02 |
| Normal-vs-N1 |
2.420000E-03 |
| Normal-vs-N2 |
6.848000E-02 |
| N0-vs-N1 |
2.559600E-02 |
| N0-vs-N2 |
7.751800E-01 |
| N1-vs-N2 |
4.876800E-01 |
|
|
